207 related articles for article (PubMed ID: 8111699)
1. Treatment of hepatocellular carcinoma with transcatheter arterial embolization. Analysis of prognostic factors.
Taniguchi K; Nakata K; Kato Y; Sato Y; Hamasaki K; Tsuruta S; Nagataki S
Cancer; 1994 Mar; 73(5):1341-5. PubMed ID: 8111699
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
[TBL] [Abstract][Full Text] [Related]
3. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization.
Shin BS; Park MH; Jeon GS
Acta Radiol; 2011 Apr; 52(3):331-5. PubMed ID: 21498371
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and factors influencing survival in cirrhotic cases with spontaneous rupture of hepatocellular carcinoma: a multicenter study.
Kirikoshi H; Saito S; Yoneda M; Fujita K; Mawatari H; Uchiyama T; Higurashi T; Imajo K; Sakaguchi T; Atsukawa K; Sawabe A; Kanesaki A; Takahashi H; Abe Y; Inamori M; Kobayashi N; Kubota K; Ueno N; Nakajima A
BMC Gastroenterol; 2009 Apr; 9():29. PubMed ID: 19405938
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; Lleo de Nalda A; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
PLoS One; 2020; 15(6):e0232371. PubMed ID: 32555707
[TBL] [Abstract][Full Text] [Related]
6. Treatment of ruptured hepatocellular carcinoma.
Tanaka A; Takeda R; Mukaihara S; Hayakawa K; Shibata T; Itoh K; Nishida N; Nakao K; Fukuda Y; Chiba T; Yamaoka Y
Int J Clin Oncol; 2001 Dec; 6(6):291-5. PubMed ID: 11828948
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of patients with spontaneous rupture of hepatocellular carcinoma in cirrhosis.
Tarantino L; Sordelli I; Calise F; Ripa C; Perrotta M; Sperlongano P
Updates Surg; 2011 Mar; 63(1):25-30. PubMed ID: 21258886
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter arterial embolization for hepatocellular carcinoma with portal vein thrombosis.
Yen FS; Wu JC; Kuo BI; Chiang JH; Chen TZ; Lee SD
J Gastroenterol Hepatol; 1995; 10(3):237-40. PubMed ID: 7548796
[TBL] [Abstract][Full Text] [Related]
10. New therapy complementary to transcatheter arterial embolization for hepatocellular carcinoma.
Yamada R; Nakamura K; Nishida N; Matsuoka T; Yamada K; Tanaka K; Terada M; Sato M
World J Surg; 2001 Mar; 25(3):381-5; discussion 385-6. PubMed ID: 11343199
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
[TBL] [Abstract][Full Text] [Related]
12. The outcome of hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Hsieh MY; Wu DK; Lu SN; Wang LY; Chang WY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1990 Nov; 6(11):628-35. PubMed ID: 2175816
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma.
Nakao N; Uchida H; Kamino K; Nishimura Y; Ohishi H; Takayasu Y; Nakamura H; Kuroda C; Fujita M; Yoshioka H
Cancer Chemother Pharmacol; 1992; 31 Suppl():S72-6. PubMed ID: 1333913
[TBL] [Abstract][Full Text] [Related]
14. Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate.
Matsui O; Kadoya M; Yoshikawa J; Gabata T; Takashima T; Demachi H
Cancer Chemother Pharmacol; 1994; 33 Suppl():S84-8. PubMed ID: 8137490
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of hepatectomy in small hepatocellular carcinoma--comparison with transcatheter arterial embolization therapy].
Segawa T; Izawa K; Tsunoda T; Kanematsu T; Shima M; Matsunaga N; Hayashi K
Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):1095-9. PubMed ID: 1335113
[TBL] [Abstract][Full Text] [Related]
16. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
17. Management of spontaneous bleeding due to hepatocellular carcinoma.
Recordare A; Bonariol L; Caratozzolo E; Callegari F; Bruno G; Di Paola F; Bassi N
Minerva Chir; 2002 Jun; 57(3):347-56. PubMed ID: 12029230
[TBL] [Abstract][Full Text] [Related]
18. The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study.
Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee PC; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Chau GY; Chiang JH; Lui WY; Lee SD; Wu JC
Liver Int; 2004 Oct; 24(5):419-24. PubMed ID: 15482337
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic value of hepatectomy and transcatheter arterial embolization (TAE) for hepatocellular carcinoma].
Takeda S; Tashiro H; Koho H; Abe Y; Nagafuchi Y; Okamoto K; Ohsato K
Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):1100-3. PubMed ID: 1335114
[TBL] [Abstract][Full Text] [Related]
20. Zinc metabolism after transcatheter arterial embolization for hepatocellular carcinoma.
Ohmoto K; Yamamoto S
Hepatogastroenterology; 1998; 45(22):1082-4. PubMed ID: 9756010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]